Joana Pimenta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Joana Pimenta has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
- Paulo Bettencourt
University of Porto Medical School, Porto, Portugal
28 shared publications - Ana Azevedo
Universidade do Porto, Portugal; Universidade do Porto, Portugal
12 shared publications - António Ferreira
Heart Failure Clinic, Serviço de Medicina Interna—Hospital S. João, Faculdade de Medicina da Universidade do Porto, Unidade I&D Cardiovascular do Porto , Alameda Prof. Hernani Monteiro, 4202-451, Porto
9 shared publications - Fernando Friões
Department of Medicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
9 shared publications - Francisco Rocha-Gonçalves
Unit of Cardiovascular Research & Development, University of Porto Medical School, Porto, Portugal
7 shared publications - Francisco Sampaio
Department of Cardiology, Unidade Local de Saúde de Gaia e Espinho, Vila Nova de Gaia, Portugal
6 shared publications
Latest Publications
- Open Access
- 8 May 2026
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 45 (7) , 377-392
Practical guide on acute heart failure management: From hospital admission to outpatient care
- 8 May 2026
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 45 (7) , 377-392
Open AccessPractical guide on acute heart failure management: From hospital admission to outpatient care
- Open Access
- 6 March 2024
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 123, 4-14
Acute heart failure – an EFIM guideline critical appraisal and adaptation for internists
- 6 March 2024
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 123, 4-14
Open AccessAcute heart failure – an EFIM guideline critical appraisal and adaptation for internists
- Open Access
- 20 September 2021
- Published by Sociedade Portuguesa de Medicina Interna in Medicina Interna
- Vol. 28 (1) , 76-81
Checklist para A Pré-Alta de Internamento por Insuficiência Cardíaca
A insuficiência cardíaca (IC) é um problema grave de saúde pública em Portugal, estando associada a elevada morbilidade e mortalidade. A gestão clínica do doente com IC é complexa, sendo necessário melhorar a consciencialização para a doença e a articulação entre os cuidados de saúde. Os doentes com IC são frequentemente hospitalizados devido a episódios agudos da doença. Estes internamentos são uma oportunidade para a otimização da abordagem da IC. De acordo com as recomendações internacionais, devem ser utilizadas checklists na gestão dos doentes com IC em contexto hospitalar, para melhorar a gestão clínica do doente e diminuir o impacto clínico e financeiro desta síndrome. Neste position statement o Núcleo de Estudos de Insuficiência Cardíaca (NEIC) da Sociedade Portuguesa de Medicina Interna (SPMI) propõe uma checklist para a pré-alta hospitalar para melhorar a abordagem do doente internado por IC em Portugal. A checklist proposta teve em conta as recomendações internacionais para a abordagem da IC, adaptando-as à realidade da prática clínica, epidemiologia e demografia de Portugal.
- 20 September 2021
- Published by Sociedade Portuguesa de Medicina Interna in Medicina Interna
- Vol. 28 (1) , 76-81
Open AccessChecklist para A Pré-Alta de Internamento por Insuficiência Cardíaca
A insuficiência cardíaca (IC) é um problema grave de saúde pública em Portugal, estando associada a elevada morbilidade e mortalidade. A gestão clínica do doente com IC é complexa, sendo necessário melhorar a consciencialização para a doença e a articulação entre os cuidados de saúde. Os doentes com IC são frequentemente hospitalizados devido a episódios agudos da doença. Estes internamentos são uma oportunidade para a otimização da abordagem da IC. De acordo com as recomendações internacionais, devem ser utilizadas checklists na gestão dos doentes com IC em contexto hospitalar, para melhorar a gestão clínica do doente e diminuir o impacto clínico e financeiro desta síndrome. Neste position statement o Núcleo de Estudos de Insuficiência Cardíaca (NEIC) da Sociedade Portuguesa de Medicina Interna (SPMI) propõe uma checklist para a pré-alta hospitalar para melhorar a abordagem do doente internado por IC em Portugal. A checklist proposta teve em conta as recomendações internacionais para a abordagem da IC, adaptando-as à realidade da prática clínica, epidemiologia e demografia de Portugal.
- 22 October 2016
- Published by Morressier GmbH
HYPERTENSIVE EMERGENCIES IN CRITICALLY ILL PATIENTS: A 15-YEAR PICU EXPERIENCE
- 22 October 2016
- Published by Morressier GmbH
HYPERTENSIVE EMERGENCIES IN CRITICALLY ILL PATIENTS: A 15-YEAR PICU EXPERIENCE
- 23 February 2016
- Published by Elsevier in Revista Clínica Española
- Vol. 216 (3) , 126-127
A new tool to measure hydration status in acute heart failure – Is bioelectrical impedance vector analysis (BIVA) making its way to the wards?
- 23 February 2016
- Published by Elsevier in Revista Clínica Española
- Vol. 216 (3) , 126-127
A new tool to measure hydration status in acute heart failure – Is bioelectrical impedance vector analysis (BIVA) making its way to the wards?
- Open Access
- 1 January 2016
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 22 (1) , 112-25
Left ventricular function assessment in cirrhosis: Current methods and future directions
Cirrhotic cardiomyopathy has been defined as a chronic cardiac dysfunction in patients with cirrhosis characterized by impaired contractile responsiveness to stress and/or altered diastolic relaxation with electrophysiological abnormalities in the absence of other known cardiac disease. Non-invasive cardiovascular imaging modalities play a major role in unmasking systolic and diastolic dysfunction in patients with cirrhosis. Echocardiography has been the most commonly used modality for assessing myocardial function in these patients. Conventional echocardiographic indices rely on several assumptions that may limit their applicability in patients with a hyperdynamic circulation. Newer imaging modalities may contribute to a more accurate diagnosis of cardiovascular abnormalities in cirrhotic patients, thereby influencing clinical management. We aimed to review the different non-invasive imaging technologies currently used for assessing left ventricular systolic and diastolic function in cirrhosis, as well as to describe new imaging modalities with potential clinical applicability in the near future.
- 1 January 2016
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 22 (1) , 112-25
Open AccessLeft ventricular function assessment in cirrhosis: Current methods and future directions
Cirrhotic cardiomyopathy has been defined as a chronic cardiac dysfunction in patients with cirrhosis characterized by impaired contractile responsiveness to stress and/or altered diastolic relaxation with electrophysiological abnormalities in the absence of other known cardiac disease. Non-invasive cardiovascular imaging modalities play a major role in unmasking systolic and diastolic dysfunction in patients with cirrhosis. Echocardiography has been the most commonly used modality for assessing myocardial function in these patients. Conventional echocardiographic indices rely on several assumptions that may limit their applicability in patients with a hyperdynamic circulation. Newer imaging modalities may contribute to a more accurate diagnosis of cardiovascular abnormalities in cirrhotic patients, thereby influencing clinical management. We aimed to review the different non-invasive imaging technologies currently used for assessing left ventricular systolic and diastolic function in cirrhosis, as well as to describe new imaging modalities with potential clinical applicability in the near future.
- 1 October 2015
- Published by Elsevier in JACC: Heart Failure
- Vol. 3 (10) , 751-761
Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure
- 1 October 2015
- Published by Elsevier in JACC: Heart Failure
- Vol. 3 (10) , 751-761
Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure
- 1 August 2015
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 16 (8) , 576-582
Higher BMI in heart failure patients is associated with longer survival only in the absence of diabetes
We conducted a retrospective cohort study on 503 ambulatory systolic heart failure patients attending a heart failure clinic, based on abstraction of data from clinical records. Patients were compared according to diabetes history. BMI was analyzed as a continuous variable and dichotomized using 25 kg/m2 as cut-off. Patients’ follow-up was censored at 5 years and all-cause death was the endpoint under study. Results The median age was 69 years and 68% were men; 184 (36.6%) patients had diabetes upon referral. During follow-up, 95 nondiabetic and 69 diabetic patients died. Higher BMI was associated with longer survival in the whole sample, but this association was only reproduced in the subgroup of patients without diabetes [hazard ratio = 0.93; 95% confidence interval (CI): 0.89–0.98 per kg/m2 vs. hazard ratio = 0.99; 95% CI: 0.94–1.04 in diabetic patients; P for interaction = 0.009]. BMI below 25 kg/m2 increased the risk of death by 1.90-fold (95% CI: 1.23–2.94) with a null association in diabetic patients (P for interaction = 0.012). The association between BMI and mortality in nondiabetic heart failure patients was independent of other predictors of prognosis. Conclusion The reported obesity paradox in heart failure can only be observed in nondiabetic patients....
- 1 August 2015
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 16 (8) , 576-582
Higher BMI in heart failure patients is associated with longer survival only in the absence of diabetes
We conducted a retrospective cohort study on 503 ambulatory systolic heart failure patients attending a heart failure clinic, based on abstraction of data from clinical records. Patients were compared according to diabetes history. BMI was analyzed as a continuous variable and dichotomized using 25 kg/m2 as cut-off. Patients’ follow-up was censored at 5 years and all-cause death was the endpoint under study. Results The median age was 69 years and 68% were men; 184 (36.6%) patients had diabetes upon referral. During follow-up, 95 nondiabetic and 69 diabetic patients died. Higher BMI was associated with longer survival in the whole sample, but this association was only reproduced in the subgroup of patients without diabetes [hazard ratio = 0.93; 95% confidence interval (CI): 0.89–0.98 per kg/m2 vs. hazard ratio = 0.99; 95% CI: 0.94–1.04 in diabetic patients; P for interaction = 0.009]. BMI below 25 kg/m2 increased the risk of death by 1.90-fold (95% CI: 1.23–2.94) with a null association in diabetic patients (P for interaction = 0.012). The association between BMI and mortality in nondiabetic heart failure patients was independent of other predictors of prognosis. Conclusion The reported obesity paradox in heart failure can only be observed in nondiabetic patients....
- 29 July 2015
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 17 (9) , 936-944
Challenging the Two Concepts in Determining the Appropriate Pre-Discharge N-Terminal Pro-Brain Natriuretic Peptide Treatment Target in Acute Decompensated Heart Failure Patients: Absolute or Relative Discharge Levels?
Aims: NT-proBNP is a strong predictor for readmissions and mortality in acute decompensated heart failure (ADHF) patients. We assessed whether absolute or relative NT-proBNP levels should be used as pre discharge treatment target. Methods and results: Our study population was assembled from seven ADHF cohorts. We defined absolute (50, and >70%). Population attributable risk fraction (PARF) is the proportion of all-cause 6-month mortality in the population that would be reduced if all patients attain the NT-proBNP target. PARF was determined for each target as well as the percentage of patients attaining the NT-proBNP target. Attainability was investigated by logistic regression analysis. A total of 1266 patients [age 74 (64–80), 60% male] was studied. For every absolute NT-proBNP level, a corresponding percentage reduction was found that resulted in similar PARFs. The highest PARF (∼60–70%) was observed for 70%, but attainability was low (27% and 22%, respectively). The strongest predictor for not attaining these targets was admission NT-proBNP. In admission NT-proBNP tertiles, PARFs were significantly different for absolute, but not for relative targets. Conclusion: In an ADHF population, pre-discharge absolute or relative NT-proBNP targets may both be useful as they have similar effects on PARF. However, depending on admission NT-proBNP, absolute targets show varying PARFs, while PARFs for relative targets were similar. A relative target is predicted to reduce mortality consistently across the whole spectrum of ADHF patients, while this is not the case using a single absolute target.
- 29 July 2015
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 17 (9) , 936-944
Challenging the Two Concepts in Determining the Appropriate Pre-Discharge N-Terminal Pro-Brain Natriuretic Peptide Treatment Target in Acute Decompensated Heart Failure Patients: Absolute or Relative Discharge Levels?
Aims: NT-proBNP is a strong predictor for readmissions and mortality in acute decompensated heart failure (ADHF) patients. We assessed whether absolute or relative NT-proBNP levels should be used as pre discharge treatment target. Methods and results: Our study population was assembled from seven ADHF cohorts. We defined absolute (50, and >70%). Population attributable risk fraction (PARF) is the proportion of all-cause 6-month mortality in the population that would be reduced if all patients attain the NT-proBNP target. PARF was determined for each target as well as the percentage of patients attaining the NT-proBNP target. Attainability was investigated by logistic regression analysis. A total of 1266 patients [age 74 (64–80), 60% male] was studied. For every absolute NT-proBNP level, a corresponding percentage reduction was found that resulted in similar PARFs. The highest PARF (∼60–70%) was observed for 70%, but attainability was low (27% and 22%, respectively). The strongest predictor for not attaining these targets was admission NT-proBNP. In admission NT-proBNP tertiles, PARFs were significantly different for absolute, but not for relative targets. Conclusion: In an ADHF population, pre-discharge absolute or relative NT-proBNP targets may both be useful as they have similar effects on PARF. However, depending on admission NT-proBNP, absolute targets show varying PARFs, while PARFs for relative targets were similar. A relative target is predicted to reduce mortality consistently across the whole spectrum of ADHF patients, while this is not the case using a single absolute target.